⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.

DEEPAKNTR - Fundamental Analysis: Financial Health & Valuation

← Back to List

⭐ Rating: 3.8

Last Updated Time : 02 Aug 26, 05:46 pm

Key Parameters

⭐ Fundamental Rating: 3.8

Stock CodeDEEPAKNTR
Market Cap22,699 Cr.
Current Price1,659 ₹
High / Low1,904 ₹
Stock P/E117
Book Value236 ₹
Dividend Yield0.45 %
ROCE7.36 %
ROE6.14 %
Face Value2.00 ₹
DMA 501,656 ₹
DMA 2001,688 ₹
Chg in FII Hold0.05 %
Chg in DII Hold0.30 %
PAT Qtr38.8 Cr.
PAT Prev Qtr15.5 Cr.
RSI50.4
MACD4.60
Volume1,44,095
Avg Vol 1Wk1,06,795
Low price1,280 ₹
High price1,904 ₹
PEG Ratio-4.67
Debt to equity0.02
52w Index60.7 %
Qtr Profit Var-28.0 %
EPS13.8 ₹
Industry PE29.2

✅ Positive

Deepak Nitrite demonstrates strong revenue growth with a significant increase in PAT compared to the previous quarter, indicating operational improvements and increased demand. The company’s debt levels are extremely low contributing to a healthy balance sheet.

⚠️ Limitation

Despite recent momentum shifts, the stock remains significantly overvalued relative to its industry peers, and fluctuations in market volatility could impact the share price. The Qtr Profit Variance of -28% indicates a challenging period for profitability, which needs monitoring.

📉 Company Negative News

Recent news highlights that Deepak Nitrite is distributing dividends today, suggesting potential pressure on earnings and perhaps limited reinvestment opportunities. Market volatility is creating an uncertain environment for technical momentum shifts.

📈 Company Positive News

The market has shifted to mildly bullish momentum for Deepak Nitrite. A dividend payout date of Rs 65 was announced for Wipro, Deepak Nitrite, Persistent Systems, and other stocks traded ex-date on July 27th, suggesting some positive financial action from the company.

🏭 Industry

The chemical sector is currently experiencing moderate growth driven by increased demand across various end-user industries such as pharmaceuticals, agrochemicals, and paints & coatings. However, the industry remains sensitive to raw material price fluctuations and global economic conditions.

🧾 Conclusion

We recommend an entry zone between 1,400 ₹ – 1,500 ₹, reflecting a potential undervaluation given its growth trajectory and low debt. Long-term holding guidance suggests focusing on the company's strategic expansion into specialty chemicals and maintaining a disciplined approach to valuation monitoring. This stock presents a moderate risk/reward profile with strong fundamentals but requires careful observation of earnings performance and macroeconomic factors.

Technical Analysis
Fundamental Analysis

NIFTY 50 · Fundamental

NEXT 50 · Fundamental

MIDCAP · Fundamental

SMALLCAP · Fundamental